Idera Pharmaceuticals Inc Stock Nasdaq
Equities
US45168K3068
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | - | Sales 2022 | 4.86M | Capitalization | 3.12M |
---|---|---|---|---|---|
Net income 2021 | 98M | Net income 2022 | -23M | EV / Sales 2021 * | - |
Net cash position 2021 * | - | Net cash position 2022 * | - | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 38.12% |
1st Jan change | Capi. | |
---|---|---|
-1.69% | 41.35B | |
+42.15% | 40.38B | |
+3.16% | 39.05B | |
-12.11% | 26.67B | |
+1.89% | 24.07B | |
-23.74% | 18.36B | |
-3.67% | 11.68B | |
+21.18% | 11.6B | |
+7.45% | 11.15B |